- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-0556
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
DNA vaccine constructs against enterovirus 71 elicit immune response in mice ; volume:5 ; number:1 ; day:19 ; month:4 ; year:2007 ; pages:1-13 ; date:12.2007
Genetic vaccines and therapy ; 5, Heft 1 (19.4.2007), 1-13, 12.2007
- Creator
-
Tung, Wong Siew
Bakar, Sazaly Abu
Sekawi, Zamberi
Rosli, Rozita
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-0556-5-6
- URN
-
urn:nbn:de:101:1-2021082808083403310964
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tung, Wong Siew
- Bakar, Sazaly Abu
- Sekawi, Zamberi
- Rosli, Rozita
- SpringerLink (Online service)
Other Objects (12)
Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections
Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
Suppression of interleukin-6 increases enterovirus A71 lethality in mice
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Sugar signals from oral glucose transporters elicit cephalic-phase insulin release in mice
Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication
Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection
Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections
Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
Suppression of interleukin-6 increases enterovirus A71 lethality in mice
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Sugar signals from oral glucose transporters elicit cephalic-phase insulin release in mice
Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication
Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection
Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections
Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
Suppression of interleukin-6 increases enterovirus A71 lethality in mice
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Sugar signals from oral glucose transporters elicit cephalic-phase insulin release in mice
Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication